Genetic antimicrobial resistance determinants and their prevalence in molecular subtypes of Treponema pallidum subsp. pallidum | CMAC

Genetic antimicrobial resistance determinants and their prevalence in molecular subtypes of Treponema pallidum subsp. pallidum

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):216-221

​ Obraztsova O.A., Aleynikova K.A., Obukhov A.P., Kubanov A.A., Deryabin D.G.
10.36488/cmac.2018.3.216-221
Treponema pallidum antimicrobial resistance genetic determinants molecular typing
Section
Antimicrobial Resistance
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):216-221

Objective.

To investigate genetic determinants of resistance to antimicrobial agents recommended for the treatment of syphilis and assess their prevalence in molecular subtypes of Treponema pallidum subsp. pallidum in the Russian Federation over the period of 2014-2017.

Materials and Methods.

A total of 161 clinical isolates of T. pallidum obtained from Tyva, Stavropol, Irkutsk, Kaluga, Novosibirsk and Omsk regions were included in this study. Genetic material of T. pallidum was detected by PCR with primers to polA gene. Determinants of resistance to penicillins (tromp1, tp47), tetracyclines (16S rRNA) and macrolides (23S rRNA) were determined using the gene sequence analysis. Molecular typing was performed by characterizing variable arp, tpr (E, G, J) and tp0548 genes according to the CDC protocol. Results of this study were compared to historical data on antimicrobial resistance of T. pallidum over the period of 2011-2012.

Results.

Analysis of tromp1 and tp47 gene sequences detected C22G and G208T substitutions, respectively. These polymorphisms were not significant for activity of the corresponding proteins, but differed the studied clinical isolates from the reference strain Nichols, therefore, linking them with epidemic genogroup T. pallidum Street Strain 14. Based on the analysis of G1058C mutation in the 16S rRNA gene, all clinical isolates obtained in 2014-2017 belonged to wild type, whereas this genetic determinant of resistance to tetracyclines was determined in 2 of 190 isolates obtained in 2011-2012. Also, A2059G/C mutation in the 23S rRNA gene was not found, whereas a significant A2058G substitution in this gene was determined in 4 isolates obtained in 2014-2017. Results of this study confirm sporadic resistance to macrolides in the Russian Federation, which was previously (2011-2012) found in 3 of 190 isolates of T. pallidum. A2058G mutation was detected predominantly in minor subtypes of T. pallidum (14 b/f, 14 b/g and 14 d/g) and was unrepresentative for molecular subtype 14 d/f which is a predominant one in the Russian Federation.

Conclusions.

The long-term use of penicillins for the treatment of syphilis did not result in emergence of T. pallidum resistance to this antibiotic class. An absence of genetic determinants of resistance to tetracyclines confirms them to be second-line drugs. A sporadic prevalence of determinants of resistance to macrolides requires they be used for the treatment of syphilis with caution.

Obraztsova O.A.

State Scientific Center of Dermatology, Venerology and Cosmetology, Moscow, Russia

Aleynikova K.A.

State Scientific Center of Dermatology, Venerology and Cosmetology, Moscow, Russia

Obukhov A.P.

Tyva Republican Dermatovenerologic Dispensary, Kyzyl, Russia

Kubanov A.A.

State Scientific Center of Dermatology, Venerology and Cosmetology, Moscow, Russia

Dmitry G. Deryabin

State Scientific Center of Dermatology, Venerology and Cosmetology, Moscow, Russia

  • 1. WHO Guidelines for the treatment of Treponema pallidum (syphilis) [editorial]. 2016. Available at: http://www.who.int/reproductivehealth/publications/rtis/syphilis-treatment-guidelines/en/
  • 2. Federal clinical guidelines. Dermatovenerology 2015: Skin diseases. Sexually Transmitted Infections. 5th Ed., M.: Delovoj jekspress, 2016. 768 p. Russian.
  • 3. Siguier M., Molina J.M. Doxycycline prophylaxis for bacterial sexually transmitted infections: promises and perils. ACS Infectious Diseases. 2018;4(5):660-663.
  • 4. Yang C.J., Tang H.J., Chang S.Y., et al. Comparison of serological responses to single-dose azithromycin (2 g) versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients in an area of low prevalence of macrolide-resistant Treponema pallidum infection. J Antimicrob Chemother. 2016;71(3):775-782.
  • 5. Yuping Cao, Xiaohong Su, Qianqiu Wang, et al. A multicenter study evaluating ceftriaxone and benzathine penicillin G as treatment agents for early syphilis in Jiangsu, China. Clin Infect Dis. 2017;65(10):1683-1688.
  • 6. Chia-Jui Yang, Nan-Yao Lee, Tun-Chieh Chen, et al. One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One. 2014;9(10):e109667.
  • 7. Blencowe H., Cousens S., Kamb M., Berman S., Lawn J.E. Lives saved tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health. 2011;11(Suppl 3):S9.
  • 8. Stamm L.V. Global Challenge of Antibiotic-Resistant Treponema pallidum. Antimicrob Agents Chemother. 2010;54(2):583-589.
  • 9. Kubanova A.A., Kubanov A.A., Frigo N.V., et al. First experience of molecular typing and determining the antibiotic resistance of syphilis pathogen Treponema pallidum in the Russian Federation. Vestnik dermatologii i venerologii. 2013;(3):34-46. Russian.
  • 10. Pillay A., Liu H., Chen C.Y., et al. Molecular subtyping of Treponema pallidum subspecies pallidum. Sex Transm Dis. 1998;25(8):408-414.
  • 11. Pope V., Fox K., Liu H., et al. Molecular Subtyping of Treponema pallidum from North and South Carolina. J Clin Microbiol. 2005;43(8):3743-3746.
  • 12. Kubanov A.A., Vorob’ev D.V., Obraztsova O.A., Deryabin D.G., Obukhov A.P. Molecular epidemiology of Treponema pallidum in a Frontier region of the Russian Federation (Tuva Republic). Molekuljarnaja genetika, mikrobiologija i virusologija. 2017;35(1):26-30. Russian.
  • 13. Deka R.K., Machius M., Norgard M.V., Tomchick D.R. Crystal structure of the 47-kDa lipoprotein of Treponema pallidum reveals a novel penicillin-binding protein. J Biol Chem. 2002;277:41857-41864.
  • 14. Goffin C., Ghuysen J.M. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol Mol Biol Rev. 1998;62(4):1079-1093.
  • 15. Blanco D.R., Champion C., Exner M.M., et al. Porin activity and sequence analysis of a 31-kilodalton Treponema pallidum subsp. pallidum rare outer membrane protein (Tromp1). J Bacteriol. 1995;177(12):3556-3562.
  • 16. Matejková P., Strouhal M., Smajs D., et al. Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays. BMC Microbiol. 2008;8:76.
  • 17. Grimes M., Sahi S.K., Gdornes B.C., et al. Two mutations associated with macrolide resistance in Treponema pallidum: increasing prevalence and correlation with molecular strain type in Seattle, Washington. Sex Transm Dis. 2012;39(12):954-958.
  • 18. Lee S.Y., Ning Y., Fenno J.C. 23S rRNA point mutation associated with erythromycin resistance in Treponema denticola. FEMS Microbiol Lett. 2002;207(1):39-42.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared